Search research articles
Contact Us
Filters
Showing results (61-70 of 81) with videos related to
Page
of 9
Sort By:
Scientific Reports
|
June 10, 2020
Iron overload alters the energy metabolism in patients with myelodysplastic syndromes: results from the multicenter FISM BIOFER study
Daniela Cilloni, Silvia Ravera, Chiara Calabrese, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
October 29, 2025
Use of patient-derived organoids for pleural mesothelioma 3-D modeling
Luca Volpini, Federica Monaco, Elisabetta Casalone, et al.
American Journal of Blood Research
|
July 5, 2012
Quality of life and physicians' perception in myelodysplastic syndromes
Esther Natalie Oliva, Carlo Finelli, Valeria Santini, et al.
British Journal of Haematology
|
April 19, 2017
Iron-chelating therapy with deferasirox in transfusion-dependent, higher risk myelodysplastic syndromes: a retrospective, multicentre study
Pellegrino Musto, Luca Maurillo, Vittorio Simeon, et al.
British Journal of Haematology
|
October 25, 2023
Ataluren improves myelopoiesis and neutrophil chemotaxis by restoring ribosome biogenesis and reducing p53 levels in Shwachman-Diamond syndrome cells
Marco Cipolli, Christian Boni, Marianna Penzo, et al.
Frontiers in Endocrinology
|
March 18, 2020
Reporting Guidelines, Review of Methodological Standards, and Challenges Toward Harmonization in Bone Marrow Adiposity Research. Report of the Methodologies Working Group of the International Bone Marrow Adiposity Society
Josefine Tratwal, Rossella Labella, Nathalie Bravenboer, et al.
Cancers
|
November 13, 2025
The Strange Case of Functional High-Risk Multiple Myeloma Patients: Is It Possible to Identify Them in Clinical Practice?
Sonia Morè, Massimo Offidani, Laura Corvatta, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
October 1, 2025
Cytogenetic Features and Their Implications in Clinical Practice: A Real-World Analysis of a Large Cohort of Multiple Myeloma Patients
Sonia Morè, Massimo Offidani, Laura Corvatta, et al.
Cancer Medicine
|
October 29, 2019
Effects of different doses of erythropoietin in patients with myelodysplastic syndromes: A propensity score-matched analysis
Enrico Balleari, Rosa Angela Filiberti, Chiara Salvetti, et al.
Cancer
|
March 19, 2021
Overall survival of myelodysplastic syndrome patients after azacitidine discontinuation and applicability of the North American MDS Consortium scoring system in clinical practice
Marino Clavio, Elena Crisà, Maurizio Miglino, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 81) with videos related to
Sort By:
Page
of 9
Scientific Reports
|
June 10, 2020
Iron overload alters the energy metabolism in patients with myelodysplastic syndromes: results from the multicenter FISM BIOFER study
Daniela Cilloni, Silvia Ravera, Chiara Calabrese, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
October 29, 2025
Use of patient-derived organoids for pleural mesothelioma 3-D modeling
Luca Volpini, Federica Monaco, Elisabetta Casalone, et al.
American Journal of Blood Research
|
July 5, 2012
Quality of life and physicians' perception in myelodysplastic syndromes
Esther Natalie Oliva, Carlo Finelli, Valeria Santini, et al.
British Journal of Haematology
|
April 19, 2017
Iron-chelating therapy with deferasirox in transfusion-dependent, higher risk myelodysplastic syndromes: a retrospective, multicentre study
Pellegrino Musto, Luca Maurillo, Vittorio Simeon, et al.
British Journal of Haematology
|
October 25, 2023
Ataluren improves myelopoiesis and neutrophil chemotaxis by restoring ribosome biogenesis and reducing p53 levels in Shwachman-Diamond syndrome cells
Marco Cipolli, Christian Boni, Marianna Penzo, et al.
Frontiers in Endocrinology
|
March 18, 2020
Reporting Guidelines, Review of Methodological Standards, and Challenges Toward Harmonization in Bone Marrow Adiposity Research. Report of the Methodologies Working Group of the International Bone Marrow Adiposity Society
Josefine Tratwal, Rossella Labella, Nathalie Bravenboer, et al.
Cancers
|
November 13, 2025
The Strange Case of Functional High-Risk Multiple Myeloma Patients: Is It Possible to Identify Them in Clinical Practice?
Sonia Morè, Massimo Offidani, Laura Corvatta, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
October 1, 2025
Cytogenetic Features and Their Implications in Clinical Practice: A Real-World Analysis of a Large Cohort of Multiple Myeloma Patients
Sonia Morè, Massimo Offidani, Laura Corvatta, et al.
Cancer Medicine
|
October 29, 2019
Effects of different doses of erythropoietin in patients with myelodysplastic syndromes: A propensity score-matched analysis
Enrico Balleari, Rosa Angela Filiberti, Chiara Salvetti, et al.
Cancer
|
March 19, 2021
Overall survival of myelodysplastic syndrome patients after azacitidine discontinuation and applicability of the North American MDS Consortium scoring system in clinical practice
Marino Clavio, Elena Crisà, Maurizio Miglino, et al.
Page
of 9